0001209191-21-034823.txt : 20210521
0001209191-21-034823.hdr.sgml : 20210521
20210521134458
ACCESSION NUMBER: 0001209191-21-034823
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210103
FILED AS OF DATE: 20210521
DATE AS OF CHANGE: 20210521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett Elizabeth A.
CENTRAL INDEX KEY: 0001764157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 21948081
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA'TA'ASIYA STREET
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-03
0
0001668243
UroGen Pharma Ltd.
URGN
0001764157
Barrett Elizabeth A.
C/O UROGEN PHARMA LTD.
400 ALEXANDER PARK
PRINCETON
NJ
08540
0
1
0
0
Chief Executive Officer
Ordinary Shares
2021-01-03
4
M
0
8807
A
237924
D
Ordinary Shares
2021-01-31
4
M
0
5000
A
242924
D
Ordinary Shares
2021-05-19
4
F
0
2185
17.5089
D
240739
D
Ordinary Shares
2021-05-19
4
F
0
1240
17.5089
D
239499
D
Restricted Stock Units
2021-01-03
4
M
0
8807
0.00
D
Ordinary Shares
8807
105689
D
Restricted Stock Units
2021-01-31
4
M
0
5000
0.00
D
Ordinary Shares
5000
10000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs.
The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs will vest on January 3, 2022.
The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021.
/s/ Jason Smith, Attorney-in-Fact
2021-05-20